Millions of people taking GLP-1 medications such as Ozempic, Wegovy, and semaglutide are learning how to navigate restaurant menus more carefully
Key updates to Section 9 recommendations: Cardiovascular: Recommendations 9.9a and 9.9b now specify GLP-1 RA or dual GIP/GLP-1 RA for patients with type 2 diabetes and symptomatic HFpEF, based on demonstrated benefits in heart failure-related symptoms and event reduction
Injection timing and consistency Semaglutide has a half-life of approximately seven days, which supports weekly dosing
Diabetes and Cancer
[DOI] [PubMed] [Google Scholar] 104.Shi S, Shuang S, Xiangdong L, Guoqiang Z, Feng D, Wenshuang Z, et al
While GLP-1 clearly affects appetite centers in the brain, adding GIP agonism might influence different neural circuits related to food reward, energy expenditure, or metabolic regulation